Effects of PCSK9 Targeting: Alleviating Oxidation, Inflammation, and Atherosclerosis.
Ontology highlight
ABSTRACT: Characterized as a chronic inflammatory disease of the large arteries, atherosclerosis is the primary cause of cardiovascular disease, the leading contributor of morbidity and mortality worldwide. Elevated plasma cholesterol levels and chronic inflammation within the arterial plaque are major mediators of plaque initiation, progression, and instability. In 2003, the protein PCSK9 (proprotein convertase subtilisin/kexin 9) was discovered to play a critical role in cholesterol regulation, thus becoming a key player in the mechanisms behind atherosclerotic plaque development. Emerging evidence suggests that PCSK9 could potentially have effects on atherosclerosis that are independent of cholesterol levels. The objective of this review was to discuss the role on PCSK9 in oxidation, inflammation
SUBMITTER: Punch E
PROVIDER: S-EPMC9238481 | biostudies-literature | 2022 Feb
REPOSITORIES: biostudies-literature
ACCESS DATA